Back to search

University of Washington

Modulating antigen-specific humoral immunity with non-differentiating B cells

Abstract

dc:description.abstract

Antibody-derived inhibitors pose an ongoing challenge to the treatment of patients with inherited protein deficiency disorders, limiting the efficacy of both protein replacement therapy and corrective gene therapy. Beyond their central role as producers of serum antibody, B cells also exhibit many unique properties that could be exploited in cell therapy applications, notably including antigen-specific recognition and the linked capacity for antigen presentation. Here we employed CRISPR/Cas9 to demonstrate that ex vivo antigen-primed Blimp1-knockout “decoy” B cells, incapable of differentiation into plasma cells, participated in and downregulated host antigen-specific humoral responses after adoptive transfer. Following ex vivo antigen pulse, adoptively transferred high affinity antigen-specific decoy B cells were diverted into germinal centers en masse, thereby reducing participation by endogenous antigen-specific B cells in T-dependent humoral responses and suppressing both cognate and linked antigen-specific IgG following immunization with conjugated antigen. This effect was dose-dependent and, importantly, did not impact concurrent unrelated antibody responses. We demonstrated the therapeutic potential of this approach by treating factor VIII (FVIII)-knockout mice with antigen-pulsed decoy B cells prior to immunization with a FVIII conjugate protein, thereby blunting the production of serum FVIII-specific IgG by an order of magnitude as well as reducing the proportion of animals exhibiting functional FVIII inhibition by 6-fold. Finally, we demonstrated that these Blimp1-deficient decoy B cells can be simultaneously gene-edited to enable constitutive secretion of the regulatory cytokine IL 10. Together, these results suggest that it will be possible to generate engineered regulatory B cells capable of modulating the activation and differentiation of antigen-specific CD4 T cells.

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Pitner, Ragan
Advisor dc:contributor.advisor
  • Rawlings, David J.

Subjects

dc:subject × 9

Rights

dc:rights
Statement dc:rights
  • none
Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Handle dc:identifier.uri
https://hdl.handle.net/1773/52060

Chain of custody

source
Harvested from
University of Washington
Base URL
digital.lib.washington.edu/server/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Pitner, Ragan. Modulating antigen-specific humoral immunity with non-differentiating B cells. 2024. https://hdl.handle.net/1773/52060